SCHEMBL5124094

SCHEMBL5124094

CC(C)(C)c1ccc([S+](c2ccc(O)cc2)c2ccc(C(C)(C)C)cc2)cc1.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
TYR P14679 1/20 0.42
UQCRB P14927 3/20 0.42
RORA P35398 1/20 0.36
ESRRG P62508 4/20 0.35
ALDH1A1 P00352 3/20 0.34
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
HSD11B1 P28845 3/20 0.32
HSD17B3 P37058 1/20 0.32
HSD17B2 P37059 1/20 0.32
GAA P10253 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP9 P14780 1/20 0.32
MMP8 P22894 1/20 0.32
MMP13 P45452 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL51945 0.93 ALDH1A1 (0.39) LMNARORAALDH1A1HSD11B1GAA
SCHEMBL678361 0.92 ALDH1A1 (0.38) LMNARORAALDH1A1HSD11B1GAA
SCHEMBL4578713 0.90 CA2 (0.38) LMNAESR1ESR2CA1CA2
SCHEMBL5856417 0.89 CA2 (0.40) LMNACA1CA2MMP1MMP2
SCHEMBL1593144 0.89 ALDH1A1 (0.40) LMNAUQCRBRORAALDH1A1HSD11B1
SCHEMBL2438153 0.89 ALDH1A1 (0.42) LMNAUQCRBRORAALDH1A1HSD11B1
SCHEMBL384049 0.88 HSD11B1 (0.38) LMNAUQCRBRORAALDH1A1HSD11B1
SCHEMBL3139767 0.88 HSD11B1 (0.38) LMNAUQCRBRORAALDH1A1HSD11B1
SCHEMBL384930 0.87 HSD11B1 (0.37) LMNAUQCRBRORAALDH1A1HSD11B1
SCHEMBL3137398 0.87 HSD11B1 (0.37) LMNAUQCRBRORAALDH1A1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396960-B2 Sulfonium salts TOYO GOSEI CO., LTD. (JP) 2008-07-08 US disclosed
US-20070219368-A1 Sulfonium salts TOYO GOSEI CO., LTD. (JP) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219368-A1 Sulfonium salts C1S, F12, C1R LMNA 3861/4885TYR 677/4885UQCRB 625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.